WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016084097) PROCESS FOR PRODUCING FIBRINOGEN AND THROMBIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/084097    International Application No.:    PCT/IN2015/000418
Publication Date: 02.06.2016 International Filing Date: 11.11.2015
IPC:
A61L 24/10 (2006.01), C07K 14/75 (2006.01), C12N 9/74 (2006.01)
Applicants: HEMARUS THERAPEUTICS LTD. [IN/IN]; 8-3-677/14, Skd Nagar, Srinagar Colony Hyderabad 500073 (IN)
Inventors: ASHOK KUMAR NUVULA; (IN).
MITALI SAMADDAR; (IN).
VADDE NEELIMA; (IN).
ZINIA CHAKRABORTY; (IN).
DUGGINENI SWAPNA SAGAR; (IN).
UMA DEVI KOMATH; (IN)
Agent: PARAMESWARAN, Uma; Scitech Patent Art Services Pvt Ltd., Plot No. 17 & 22, Apiic Tech Park, Ida, Nacharam, Hyderabad - 500076 Telangana (IN)
Priority Data:
5704/CHE/2014 13.11.2014 IN
Title (EN) PROCESS FOR PRODUCING FIBRINOGEN AND THROMBIN
(FR) PROCÉDÉ DE PRODUCTION DE FIBRINOGÈNE ET DE THROMBINE
Abstract: front page image
(EN)The present invention relates to a fibrin sealant kit comprising purified fibrinogen and thrombin. The invention particularly relates to an improved chromatographic process for the purification of thrombin and fibrinogen components devoid of any significant plasminogen and other impurities. The absence of plasminogen facilitates the exclusion of a proteolytic inhibitor (aprotinin) from among the kit components.
(FR)La présente invention concerne un kit de colle de fibrine comprenant du fibrinogène et de la thrombine purifiés. En particulier, l'invention concerne un procédé de chromatographie amélioré pour la purification des composants thrombine et fibrinogène, exempts de quantités significatives de plasminogène et d'autres impuretés. L'absence de plasminogène facilite l'exclusion d'un inhibiteur protéolytique (aprotinine) des composants du kit.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)